Advanced search×

Design, synthesis and determination of antifungal activity of 5(6)-substituted benzotriazoles

Eur J Med Chem 45(6):9 (2010) PMID 20181413

In an effort to find inhibitors that are effective against both Candida and Aspergillus spp., a series of 5(6)-(un)substituted benzotriazole analogs, represented by compounds 3a-3h and 3b'-3f', were prepared using a crystalline oxirane intermediate 1 previously synthesized in our laboratory. All the compounds were evaluated for inhibitory activity against various species of Candida and Aspergillus. Compounds 3b' (5,6-dimethylbenzotriazol-2-yl derivative), 3d (5-chlorobenzotriazol-1-yl derivative) and 3e' (6-methylbenzotriazol-1-yl derivative) exhibited potent antifungal activity, with the MICs for Candida spp. and Aspergillus niger, ranging from 1.6@mg/mL to 25@mg/mL and 12.5@mg/mL to 25@mg/mL, respectively. The present work describes the design, synthesis, regioisomer characterization (through COSY and NOESY 2D-NMR spectroscopy and single molecule X-ray crystallography), antifungal evaluation, molecular docking, and structure-activity relationships of the various 5(6)-(un)substituted benzotriazole analogs.

Copyright © 2010 Elsevier Ltd. All rights reserved.

DOI: 10.1016/j.ejmech.2010.01.062
Version: za2963e q8za6 q8zb7 q8zc2 q8zd1 q8ze9 q8zf1 q8zg7

Similar articles you may find interesting…

  1. CoMSIA study on substituted aryl alkanoic acid analogs as GPR40 agonists.

    Chem Biol Drug Des 77(5):361-72 (2011) PMID 21352503

    GPR40, a G-protein-coupled receptor has been well established to play a crucial role in regulating blood glucose levels. Hence, GPR40 is a potential target for future antidiabetic agents. The present 3D QSAR study is aimed at delineating structural parameters governing GPR40 agonisti...
  2. CoMSIA study on substituted aryl alkanoic acid analogs as GPR40 agonists.

    Chem Biol Drug Des 77(5):361-72 (2011) PMID 21352503

    GPR40, a G-protein-coupled receptor has been well established to play a crucial role in regulating blood glucose levels. Hence, GPR40 is a potential target for future antidiabetic agents. The present 3D QSAR study is aimed at delineating structural parameters governing GPR40 agonistic activity. To me...
  3. Structure-based virtual screening, synthesis and SAR of novel inhibitors of hepatitis C virus NS5B polymerase

    Bioorg Med Chem 18(13):9 (2010) PMID 20627595 PMCID PMC2956004

    We report on the identification of novel allosteric inhibitors of HCV NS5B through a combination of structure-based virtual screening, synthesis and structure-activity relationship (SAR) optimization approach. Virtual screening of 260,000 compounds from the ChemBridge database against the tetracycli...